Skip to main content

Together we are beating cancer

Donate now

Research and trials

Showing 12 out of 1670 results
A magnified image of squamous cell carcinoma, the most common type of cervical cancer.

Researchers funded by Cancer Research UK have made the biggest improvement in cervical cancer treatment in more than 20 years by changing how we use existing drugs.  Researchers funded by Cancer Research UK have made the biggest improvement in cervical cancer treatment in more than 20 years by changing how we use existing drugs. 

by Sophie Wedekind | 14 October 2024

14 October 2024

This entry is part 2 of 2 in the series Multi-cancer tests
Caitlin, who was diagnosed with Ewing sarcoma this year and is going to take part in our INTER-EWING-1 trial.

INTER-EWING-1, the largest and most ambitious study ever conducted into Ewing sarcoma, could transform how we treat the disease, which mainly affects children and young people.   INTER-EWING-1, the largest and most ambitious study ever conducted into Ewing sarcoma, could transform how we treat the disease, which mainly affects children and young people.  

by Momoko Bowles | Analysis | 25 September 2024

25 September 2024

A sample of a mouse model of a tumour seen through team Rosetta's tools.

Cancer Grand Challenges team Rosetta found how some of the most aggressive and hard-to-treat breast cancers get the energy they need to grow and spread so quickly. Now we can see about slowing them down for good. Cancer Grand Challenges team Rosetta found how some of the most aggressive and hard-to-treat breast cancers get the energy they need to grow and spread so quickly. Now we can see about slowing them down for good.

by Tim Gunn | In depth | 24 September 2024

24 September 2024

Zhe Huang

We spoke to Dr Zhe Huang about his work investigating the proteomic profiles of prostate cancer... We spoke to Dr Zhe Huang about his work investigating the proteomic profiles of prostate cancer...

by Cancer Research UK | Interview | 10 September 2024

10 September 2024

Sânziana Foia in the lab with an image of Papcup, the new HPV test she has designed for cervical screening, on a laptop.

Sânziana Foia is developing a cervical screening device designed to detect high-risk HPV in menstrual blood within minutes. It could help remove some of the biggest barriers to cervical screening, helping many more eligible people take part.  Sânziana Foia is developing a cervical screening device designed to detect high-risk HPV in menstrual blood within minutes. It could help remove some of the biggest barriers to cervical screening, helping many more eligible people take part. 

by Sadaf Shafaghmotlagh | Analysis | 4 September 2024

4 September 2024

Abdullah, Aleesha-Marie and Faye, who all took part in clinical trials funded by Cancer Research UK

Clinical trials are how we bring better cancer treatments to children and young people. For Childhood Cancer Awareness Month, we asked parents what they're actually like. Clinical trials are how we bring better cancer treatments to children and young people. For Childhood Cancer Awareness Month, we asked parents what they're actually like.

by Tom Bourton, Tim Gunn | Personal stories | 3 September 2024

3 September 2024

Microscopy image of Hodgkin's lymphoma

Since the 1970s, our work has helped double children's cancer survival in the UK. Here are some of our biggest achievements from the last 50 years that wouldn't have been possible without the support of our partners and supporters. Since the 1970s, our work has helped double children's cancer survival in the UK. Here are some of our biggest achievements from the last 50 years that wouldn't have been possible without the support of our partners and supporters.

by Cancer Research UK | In depth | 3 September 2024

3 September 2024

2D image of scientist hands with a cancer vaccine vial and needle
  • Science & Technology
  • Health & Medicine

Cancer Vaccines - where are we?

Cancer vaccine development has had many challenges. But with recent breakthroughs, new partnerships and current clinical trials, could we be closer than ever? Cancer vaccine development has had many challenges. But with recent breakthroughs, new partnerships and current clinical trials, could we be closer than ever?

by Sophie Wedekind | In depth | 8 August 2024

8 August 2024

Brain scans

Stand Up To Cancer are giving two international teams each a further £3.75m to reduce the side effects of radiotherapy and make immunotherapies work for more young patients. Stand Up To Cancer are giving two international teams each a further £3.75m to reduce the side effects of radiotherapy and make immunotherapies work for more young patients.

by Tim Gunn | Analysis | 7 August 2024

7 August 2024